AMETEK Inc. (NYSE: AME) shares are soaring 7.67% in pre-market trading on Thursday after the company reported strong third-quarter 2025 results that exceeded analyst expectations and raised its full-year guidance. The industrial tools maker's performance was driven by robust demand for its electromechanical products and margin expansion.

For the third quarter, AMETEK reported adjusted earnings per share of $1.89, beating the analyst consensus estimate of $1.76. Revenue for the quarter came in at $1.89 billion, surpassing expectations of $1.82 billion. The company's Electromechanical Group (EMG) saw a 13% increase in sales, with particularly strong performance from its Paragon Medical unit. This growth contributed to a significant 250 basis point expansion in operating income margin for the segment.

In light of the strong results, AMETEK raised its full-year 2025 adjusted earnings guidance to a range of $7.32 to $7.37 per share, up from its previous forecast of $7.06 to $7.20. The company's ability to navigate challenges and capitalize on demand in key markets has impressed investors, leading to the substantial pre-market stock price increase.